Abstract
The study of regulatory non-coding RNAs has deepened our understanding of cancer on the molecular and clinical front. MicroRNAs, which encompass over 1000 short, endogenous nucleic acids, include important candidates that drive carcinogenesis. In this discussion, we review the literature on miR-135b, purporting its role as an oncogene in multiple cancers, and we highlight STAT3 inhibition as a potential therapeutic strategy mediated by miR-135b and demonstrate particular clinical relevance to colon cancer.
| Original language | English (US) |
|---|---|
| Article number | Article 268 |
| Journal | Frontiers in Oncology |
| Volume | 3 OCT |
| DOIs | |
| State | Published - 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Colon cancer
- EGFR
- MiR-135b
- MicroRNAs
- STAT3
Fingerprint
Dive into the research topics of 'MicroRNA-135b and its circuitry networks as potential therapeutic targets in colon cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS